Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 7.975p 7.50p 8.45p - - - 714 12:02:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 5.7 -4.2 -3.0 - 13.78

Plant Health Care Share Discussion Threads

Showing 626 to 647 of 650 messages
Chat Pages: 26  25  24  23  22  21  20  19  18  17  16  15  Older
DateSubjectAuthorDiscuss
24/12/2018
07:35
With sales apparently "broadly" in line with last year (code for slightly below last year? Cue also watchout for that delayed delivery to Brazil and pushing revenues into 2019!), and then considering the apparent fact that the launch into corn has produced 'new' revenues of "close to" $1.5m....then there has obviously been a large hit to sales elsewhere, which in my book does not appear to fit with just the fact that sales in South Africa are being "restricted" until inventory has been worked off (cue and beware of a very similar situation with Plant Impact!) Even with the launch into Soybeans next year (and given the competition), I remain unconvinced that the company can achieve what they are forecasting within their existing cash reserves.
wan
21/12/2018
08:12
How can any investor trust the guidance emanating from this company? Thus, I am not convinced they have enough cash or sales to survive in their current form. And anything the Chairman says to the contrary is quite frankly worthless in my view! The market needs to fully recognise this and deliver the ultimate humiliation that Richards deserves, which should arguably be a valuation significantly below today's opening!
wan
21/12/2018
07:18
Glad I read the signals correctly and sold out completely a while ago (even if a bit late!). The share price deserves a significant discount to be applied for a terrible, but reliable, track record! As for what I think of Chris Richards, Executive Chairman of PHC, I had better not print it! But suffice to say he is reliably inaccurate......at best!
wan
21/12/2018
07:12
Another shocker,so what chance is there that they have enough funds till cash flow positive??? Not a lot !!
riddlerone
28/11/2018
16:05
Great presentation yesterday
dubai123
28/11/2018
09:07
Some would say that conveniently there is no mention of how many companies are evaluating in total though, which may be too revealing compared to previous indications (even with an additional 3)! And yes, I am now very cynical about how PHC present stuff.
wan
28/11/2018
07:42
Good news !!!!!!!!!
dubai123
21/11/2018
16:23
Here is your chance to meet with Plant Health Care: Using this unique discount code, ADVFN25, you will be able to get £25 off at Mello London 2018, a 2 day investor conference from the 26th – 27th November 2018 at the Clayton Hotel, Chiswick, London. Http://melloevents.com/mello-london/ Tickets are normally priced at £99 for two days and £79 for one. Type in ADVFN25 as the discount code. Many Thanks and take advantage of this premium offer. See you there.
advfn_sales
18/11/2018
23:23
Here is the full two day programme schedule for MelloLondon including Plant Healthcare Http://melloevents.com/wp-content/uploads/2018/11/MT16.11v2.pdf It is jam packed full of about 75 company presentations, lots of top quality speakers and panel sessions plus workshops to help with investment style and techniques etc. The pre event fun starts on the Sunday evening with a dinner and investor quiz hosted by John Lee but the main conference begins on Monday 26th November at 9am through to Tuesday 27th in the evening so do come and join us as there are still 97 tickets left... Http://melloevents.com/mello-london/ See you there.
davidosh
14/11/2018
07:33
Am I the only one reading today's RNS as non-event? They appear to be making news out of no news i.e. no growth from H2Copla over what they were forecasting. Sales by PHC to Coplacana are expected to reach $0.8m in 2018, but to be clear PHC already had sales to Coplacana of $400k in the first half and they were expecting another $400k in second half, so at least they are 'expecting' to achieve that! But again to be 'clear', they are reporting an additional $400k not $800K!
wan
09/11/2018
07:55
The reason for my comment that there is not much new about the entry into corn is that PHC entered this market in 2016 via an agreement with Talc USA - Plant Health Care Announces Agreement with Talc U.S.A. To Launch a New Product for the US Corn Market Dec 14, 2016: Plant Health Care, Inc. and Talc U.S.A. are pleased to announce that they have reached agreement on the distribution of a new product for the US corn market. hTTp://www.planthealthcare.com/plant-health-care-announces-agreement-talc-u-s-launch-new-product-us-corn-market/ So, although the recent announcement was for a new product, to announce it as the launch of a Harpin αβ product for seed treatment applications to field corn, seems to be stretching it somewhat....some would say no change there then! Especially as to date, the original product (Talc Inceptive) had little in way of sales traction. In my opinion only, the new product is also a Talc USA product. I believe there is a reasonable likelihood it is Talc's new Fluency Agent, Effusion - hxxps://www.talcusa.com/effusion/ I have a zero tolerance on commentary from management that is not 100% correct and/or that implies there is more to announcements than what there actually is, hence my decision to sell out. Bayer has a significant foothold in the market with their Fluency Agent and maybe not revealing that Harpin is in the new fluency agent was really meant not to antagonise players/agrochemical companies in this market and hinder any potential regarding PHC's new technology (maybe that has already happened given the confidence of management and then the disappointment in Brazil?)
wan
08/11/2018
08:49
So, with regard to the corn product, apparently they are still only talking to growers in the October and November period and still only in the "process of obtaining state registrations". As I suspected, meeting market expectations for the December full year look very tight indeed (in terms of both sales and timing). Readers should compare the new interview with the previous one, as my point on the lack of clarity/accuracy (I am being kind) appears quite apparent.
wan
08/11/2018
08:30
I also want to correct something I posted on here, in particular my interpretation of the following Chairman's commentary in a recent interview - Excerpt from interview - "Even more excitingly, we’re working with a very very strong partner, I’m not permitted to say who that partner is but there are four partners who represent more than 80% of the agrochemical market in the US and it’s one of them and they have access to about a quarter of those 90 million acres. They’re very very excited about this, we launched the product last week and we will be supplying to our partner over the coming weeks for delivery to farmers who take early orders before the end of this year." I interpreted that as one of the large agrochemical companies, however, PHC investor relations has confirmed to me that it is fact a large distributor (they still cannot reveal who) and not an agrochemical company. I think my interpretation was fair, hence my point about the need for greater clarity (which I don't think is the only example!) Furthermore, I have reason to believe there is not much new about the entry into corn, so I am not particularly hopeful regarding the ultimate effects in revenue. Time will of course tell!
wan
08/11/2018
08:22
Positive interview on Directors Talk. On target for cash break even and market expectations: http://bit.ly/2JNs0n0
paulfred1
08/11/2018
08:19
It might be coincidental, but the change in Adviser just adds to my concerns as to whether PHC can meet current market expectations, if not they may need another dilutive fund raising (hence change of Adivser?). As I state it may just be coincidental, but for now at least, I have sold out completely until things become much clearer and PHC commentary "clearly and unambiguously" state the facts!
wan
06/11/2018
15:23
This won't be helping one bit; https://www.nytimes.com/2018/11/05/business/soybeans-farmers-trade-war.html
callumross
06/11/2018
13:31
This price movement is all about Hendersons selling down.You can bet they have a buyer but it was not at levels of their last sale hence the drop.There is value here but normal PI s may never see it
riddlerone
06/11/2018
12:49
Clearly another fund raising will not be supported. PHC have to live with what cash they have got and importantly what they can earn going forwards...if not then there would indeed be an issue!
wan
06/11/2018
12:34
This company NEVER meets market expectations and the deals are always delayed and pushed further and further back. Been following this one for years and was invested at one point. All it ever achieves successfully is to persuade PI's to fund it for a further period IMHO.
callumross
06/11/2018
12:22
Re-evaluating PHC and the management, who never seem to get the details quite right when addressing regulated news or market commentary. In short, we need a lot less woolliness and inaccuracies and more clarity and detail, not to mention the need to actually deliver on such! The market does appear to be telling us that something is not right (compared to PHC's previous confidence that they can still meet market expectations in the final few weeks of the year), which of course remains to be seen, but nonetheless and with the year end fast approaching I decided to start selling down until the fog clears. If PHC miss market expectation, even by a small percentage, the damage inflicted may well be beyond repair. I remain open minded though, but from here on in PHC will need to "effectively" demonstrate the market is currently sending the wrong message!
wan
06/11/2018
12:21
Sadly, looking like it might be the end game for this one IMHO. Always talked a good talk for years but never delivers.
callumross
05/11/2018
07:45
I am still trying to home in on which of the big four have secured Harpin αβ for seed treatment in Corn and Soy in the US, sales for which commence this quarter (applied to seed next quarter) so it will come out/be evident at some point!
wan
Chat Pages: 26  25  24  23  22  21  20  19  18  17  16  15  Older
Your Recent History
LSE
PHC
Plant Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190119 07:53:31